Endometrial thermoablation for treatment of menorrhagia: comparison of two methods in outpatient setting

Vihko, Kimmo K.; Raitala, Reijo; Taina, Esko

doi:10.1034/j.1600-0412.2003.00110.x

Cited by 22 publications

(12 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The combined amenorrhoea and hypomenorrhoea rates seen in the current study compare favourably to those seen in published studies utilising the old Cavaterm TM system (56 -82%), despite a 33% reduction in ablation time from 15 to 10 minutes and longer follow-up (Hawe et al, 1999;Abbott et al, 2003;Alaily et al, 2003;Vihko et al, 2003). Similarly, the overall patient satisfaction with the new system is comparable to that reported in the earlier studies.…”

Section: Discussionsupporting

confidence: 91%

Outcome of the first 220 cases of endometrial balloon ablation using Cavaterm™plus

El-Toukhy

Chandakas

Grigoriadis

et al. 2004

Journal of Obstetrics and Gynaecology

View full text Add to dashboard Cite

The objective of this prospective study was to evaluate the effectiveness of day-case Cavaterm plus thermal balloon endometrial ablation in the treatment of therapy-resistant menorrhagia. The study included 220 patients with a mean age of 41 years, mean parity of 2.1 and mean duration of menorrhagia of 3.2 years. A 6-mm diameter Cavaterm plus catheter with a silicone balloon at its tip was used. The ablation time was 10 minutes at a temperature of 78 degrees C. No procedure-related operative or immediate postoperative complications were encountered. The mean follow-up period was 19 months (range 6-24 months). The amenorrhoea-hypomenorrhoea rates at the various follow-up periods ranged between 74% and 83%. At the end of follow-up, 83% of patients were satisfied with the procedure. We conclude that Cavaterm plus is a safe and effective treatment for menorrhagia and has good patient acceptability.

show abstract

Section: Discussionsupporting

confidence: 91%

Outcome of the first 220 cases of endometrial balloon ablation using Cavaterm™plus

El-Toukhy

Chandakas

Grigoriadis

et al. 2004

Journal of Obstetrics and Gynaecology

View full text Add to dashboard Cite

show abstract

“…78 The other is a RCT comparing Menotreat with Cavaterm, but again with 6-month results. 79 Patient satisfaction and bleeding outcomes were similar for the 2 devices.…”

Section: Menotreatmentioning

confidence: 89%

“…79 Balloon ablation has also been compared with MEA with the MEA device in a cost modeling exercise based upon existing data. 118 The conclusions of this group were that thermal balloon ablation and MEA were similar with respect to overall resource utilization and that both were much less expensive than hysterectomy.…”

Section: Comparisons Of One Nrea Device To Anothermentioning

confidence: 99%

Endometrial Ablation: Where Have We Been? Where Are We Going?

Munro

2006

Clinical Obstetrics &Amp; Gynecology

View full text Add to dashboard Cite

Endometrial ablation (EA) is targeted destruction of the endothelial surface of the uterine cavity. The procedure was originally designed as a less invasive alternative to hysterectomy for the symptom of heavy menstrual bleeding unrelated to structural pathology of the uterus, that was not responsive to medical therapy. More recently it has become apparent that the procedure can be performed in the presence of submucous leiomyomas, providing they meet a number of size and location criteria. The first EA serie as published in Germany in the 1930s, but the procedure did not attract much attention until the latter part of the 20th century. Currently, EA can be performed under endoscopic direction with the neodymium:yttrium alumnum garnet laser, with a radiofrequency resectoscope, or with an expanding array of nonresectoscopic EA systems. It is apparent that most but not all of the complications associated with resectoscopic endometrial ablation are eliminated with nonresectoscopic endometrial ablation, but serious morbidity has been reported with all of the newer systems to date. Success and patient satisfaction seem to be enduring in the majority of well-selected patients treated in clinical trials, but repeat surgery, usually hysterectomy, is performed in 25% to 40% by 5 years after surgery. Increased efficiencies should be realized if the procedure could be moved to an office setting.

show abstract

“…The TBEA (Thermachoice; Gynecare) system is one of the SEAT that was approved by FDA [13,14]. The efficacy of TBEA therapy depends on the degree of hyperthermia-induced coagulation of the endometrium and submucosal layers.…”

Section: Discussionmentioning

confidence: 99%

Outcome and uterine arteries Doppler velocimetry after thermal balloon endometrial ablation in menorrhagia

Abdelazim

Belal

2013

Evidence Based Womenʼs Health Journal

View full text Add to dashboard Cite

ObjectiveThis prospective study was designed to evaluate the outcome and the changes in uterine artery blood flow after thermal balloon endometrial ablation (TBEA) in cases of menorrhagia. Study design Prospective study. Patients and methods Eighty-two premenopausal women with menorrhagia were included in this study.The TBEA was carried out on cycle days 3-8. Transvaginal color Doppler measurements were obtained from the uterine arteries on both sides before ablation and repeated on the first day, 3, 6, and 12 months after TBEA. ResultsOf 82 women, 78 (95.12%) were satisfied and experienced improvement after TBEA. The end-diastolic velocity was significantly decreased 6 and 12 months after TBEA (5.0 ± 2.5 and 4.6 ± 3.0; respectively); also, the time-averaged maximum velocity was significantly decreased 6 and 12 months after TBEA (14.8 ± 3.4 and 13.9 ± 3.4, respectively). The pulsatility index was significantly increased 6 and 12 months after TBEA (1.6 ± 0.9 and 1.63 ± 0.8, respectively); also, the resistance index was significantly increased 6 and 12 months after TBEA (0.89 ± 0.2 and 0.90 ± 0.3, respectively). Conclusion TBEA induces increase in impedance of the uterine blood flow because of fibrosis in the endometrium and subendometrial layers, with a subsequent reduction in the menstrual flow.

show abstract

Endometrial thermoablation for treatment of menorrhagia: comparison of two methods in outpatient setting

Abstract: Both thermoablation techniques were well accepted by our patients and showed similar and good efficacy and patient acceptance.

Cited by 22 publications

References 19 publications

Outcome of the first 220 cases of endometrial balloon ablation using Cavaterm™plus

Outcome of the first 220 cases of endometrial balloon ablation using Cavaterm™plus

Endometrial Ablation: Where Have We Been? Where Are We Going?

Outcome and uterine arteries Doppler velocimetry after thermal balloon endometrial ablation in menorrhagia

Contact Info

Product

Resources

About